9415016

Hatch-Waxman ANDA-style action brought by Boehringer Ingelheim entities against Granules India Limited over JENTADUETO (linagliptin/metformin HCl). The suit asserted US 9,415,016 B2 plus US 10,022,379 B2, US 11,911,388 B2, US 10,973,827 B2, and US 9,155,705 B2. It was voluntarily dismissed without prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i), with plaintiffs preserving the right to re-assert.

Listed on Google Patents for US 9,415,016 under 'Family has litigation'; details were not independently verified. It is not confirmed whether US 9,415,016 itself was asserted in this case.